United States · FDA National Drug Code directory
Tapentadol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-801_38c1235a-d675-4b2d-b1a5-100427af2364
- Product NDC
- 70954-801
- Form
- SOLUTION
- Composition / generic term
- Tapentadol Hydrochloride
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260713
- Source listing expiry
- 20271231
Source-listed ingredients
- TAPENTADOL HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (70954-801-10) / 100 mL in 1 BOTTLE · 70954-801-10
- 1 BOTTLE in 1 CARTON (70954-801-20) / 200 mL in 1 BOTTLE · 70954-801-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →